For Eye Care Professionals

Position Yourself as a Leader in the Eye Care Field

Our products equip you with the most recent genetic information you need for the personalized care of your AMD patients. Macula Risk® provides the information you need to:

  • Determine your patients’ risk to nvAMD if taking supplements
  • Determine whether any of your patients are at increased risk for progression to advanced AMD.

Learn More About Our Products

“After nearly a decade of use, I can say that Macula Risk has been a key component in preserving the vision of a multitude of our patients. Instead of dreading the loss of patients’ vision and independence as I did for my first thirty years, I now get to be a part of watching folks age joyfully. As strange as it may sound, I love managing AMD patients. We use the latest science, like Macula Risk, to make the patient’s vision outlive them.”

Dr. Gregory B. Clay O.D.

American Board of Optometry, Clay-Rhynes Eye Clinic (Oklahoma)

Genetic testing is allowing me to deliver to my patients precision treatment, uniquely tailored to their specific disease status and genetic composition. This is the future of medicine.

Dr. Dorri Goldsmidt

American Optometric Society, Gardendale, Alabama

“I routinely use genetic testing to decide on AMD supplements, if any,  and to determine a patient’s risk of disease progression”
Dr. Pamela Weber, MD

Vitreoretinal Consultants of NY